Resolution: standard / high
Figure 10.
PSSM score distribution of V3 amino acid sequences from Pt.5. The PSSM score distribution of all variants from CD36- and CD26-provirus detected
in Pt.5 at the moment of therapy interruption are shown together with those from CD36-
and CD26-captured virus present one month after therapy stop. Vertical orange lines
indicate percentiles for predicted co-receptor usage as in Fig. 6.
Rozera et al. Retrovirology 2009 6:15 doi:10.1186/1742-4690-6-15
Download authors' original image